Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral
administration of TMC207 at multiple doses as determined by the rate of change of log10
colony forming units (CFU) per ml sputum over the time period Day 7-14 in participants with
smear positive pulmonary tuberculosis (TB). A control group will receive standard treatment.